Proficio Capital Partners LLC purchased a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 4,171 shares of the financial services provider’s stock, valued at approximately $695,000.
Other large investors have also modified their holdings of the company. Focus Partners Advisor Solutions LLC acquired a new position in Marsh & McLennan Companies during the 2nd quarter worth $2,153,000. Swiss Life Asset Management Ltd boosted its position in shares of Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after acquiring an additional 11,648 shares in the last quarter. Daiichi Life Insurance Co. Ltd. purchased a new position in shares of Marsh & McLennan Companies in the 2nd quarter valued at $3,880,000. Korea Investment CORP acquired a new position in Marsh & McLennan Companies during the second quarter worth approximately $46,856,000. Finally, Bank of Nova Scotia purchased a new stake in shares of Marsh & McLennan Companies in the second quarter valued at about $20,681,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Insiders Place Their Bets
In other Marsh & McLennan Companies news, Director Lloyd M. Yates sold 12,000 shares of Marsh & McLennan Companies stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total value of $2,107,800.00. Following the transaction, the director directly owned 12,001 shares of the company’s stock, valued at $2,107,975.65. The trade was a 50.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Martin South sold 7,100 shares of the firm’s stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the completion of the sale, the insider owned 16,632 shares in the company, valued at approximately $3,159,913.68. The trade was a 29.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 36,469 shares of company stock valued at $6,291,345. Corporate insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Stock Up 0.1%
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.89 by $0.07. The firm had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The business’s quarterly revenue was up 6.2% compared to the same quarter last year. Analysts expect that Marsh & McLennan Companies, Inc. will post 10.43 EPS for the current fiscal year.
Marsh & McLennan Companies Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were paid a dividend of $0.99 per share. This represents a $3.96 annualized dividend and a yield of 2.0%. The ex-dividend date was Thursday, July 23rd. This is a positive change from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. Marsh & McLennan Companies’s dividend payout ratio is currently 48.41%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on the stock. Mizuho lifted their price target on shares of Marsh & McLennan Companies from $197.00 to $201.00 and gave the company a “neutral” rating in a research report on Wednesday, July 22nd. Citigroup downgraded Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 price target for the company. in a report on Wednesday, July 22nd. Morgan Stanley lifted their target price on Marsh & McLennan Companies from $180.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 19th. JPMorgan Chase & Co. raised their price objective on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Finally, Piper Sandler reduced their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $203.50.
Read Our Latest Research Report on MRSH
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
- Five stocks we like better than Marsh & McLennan Companies
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
